The Motley Fool Previous Page


1-Star Stocks Poised to Plunge: Peregrine Pharmaceuticals?

http://www.fool.com/investing/general/2012/08/14/1-star-stocks-poised-to-plunge-peregrine-pharmace.aspx

Brian D. Pacampara
August 14, 2012

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Peregrine Pharmaceuticals (Nasdaq: PPHM  ) has received the dreaded one-star ranking.

With that in mind, let's take a closer look at Peregrine's business and see what CAPS investors are saying about the stock right now.

Peregrine facts

Headquarters (founded) Tustin, Calif. (1981)
Market Cap $298.0 million
Industry Biotechnology
Trailing-12-Month Revenue $15.2 million
Management CEO Steven King (since 2003)
CFO Paul Lytle (since 2002)